Human CD4 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human CD4 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD4 |
| Clone | [QS4120] |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1k |
| Format | no preservative |
| Size | 0.1 mg |
| Concentration | 1.0 mg/ml |
| Applications | Flow Cytometry (FC/FACS), ELISA (EIA), FX, Blocking |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Information: Human CD4 is a cell surface glycoprotein of 55 kd expressed on most thymocytes, on about two thirds of peripheral T cells, and on some monocyte macrophage lineage cells. CD4 interacts with MHC Class II molecules in an accessory role during foreign antigen recognition by T cells. The extracellular portion of CD4 is an array of four Ig-like domains. The amino terminal region of CD4 is a receptor for the HIV-1 viral protein gp120. Antibody QS4120 recognizes the domain 1 region of the CD4 molecule. Antibody QS4120 will block binding of HIV-1 gp120 protein to CD4 and also blocks HLA Class II Rosette formation. |
| Immunogen | Immunogen: CD4 transfectant/ CEM |
| Other Names | [human CD4], [CD4; CD4; CD4mut] |
| Gene, Accession # | [CD4], Gene ID: 920, NCBI: CAA60883.1, UniProt: Q13969 |
| Catalog # | MBS666225 |
| Price | $270 |
| Order / More Info | Human CD4 Antibody from MYBIOSOURCE INC. |
| Product Specific References | D. Healey, et al, (1990) J Exp Med 172: 1233-1242. Leukocyte Typing IV (W. Knapp, et al, eds.) Oxford University Press, Oxford, (1989) p. 314-330. Leukocyte Typing V (S.F. Schlossman, et al, eds.) Oxford University Press, Oxford, (1995) p. 476-478. R. Konig, et al, (1995) J Exp Med 182: 779-787. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies